Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers

Brief description of study

This study will assess the safety and efficacy of using gene therapy via intramuscular
injections of the calf for patients with chronic non-healing foot ulcers.

Detailed Study Description

A phase III, randomized, double-blind, placebo-controlled, multicenter, 7-month study
designed to assess the safety and efficacy of intramuscular (IM) injections in the calf of
VM202 in patients with chronic nonhealing foot ulcers. Three hundred patients will be
randomized in a 2:1 ratio of VM202 or placebo injections: